SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Blackbridge Capital LLC, et al. – ‘SC 13G’ on 12/19/14 re: Therapy Cells Inc

On:  Friday, 12/19/14, at 1:37pm ET   ·   Accession #:  1171520-14-806   ·   File #:  5-88461

Previous ‘SC 13G’:  ‘SC 13G’ on 10/6/14   ·   Next:  ‘SC 13G’ on 12/30/14   ·   Latest:  ‘SC 13G/A’ on 7/13/17

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/19/14  Blackbridge Capital LLC           SC 13G                 1:64K  Therapy Cells Inc                 Elec Publishing Svcs Inc
          Blackbridge Capital, LLC

Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Blackbridge Capital / Therapy Cells                 HTML     33K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. _)*

 

Therapy Cells, Inc.
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
 
88337C102
(CUSIP Number)
 
12/8/2014
(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  Rule 13d-1(b)
     
  Rule 13d-1(c)
     
  Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 

 

 
 
 

 

CUSIP No 88337C102   Page 2 of 5

 

 

1

 

NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE  PERSONS
(ENTITIES ONLY) 

Blackbridge Capital, LLC

Tax Identification number: 46-1044853

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a)

(b)

 

3

 

SEC USE ONLY

 

 

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware
NUMBER OF
SHARES
5 SOLE VOTING POWER 117,500,000
BENEFICIALLY
OWNED BY
6 SHARED VOTING POWER  
EACH
REPORTING
7 SOLE DISPOSITIVE POWER 117,500,000
PERSON
WITH:
8 SHARED DISPOSITIVE POWER  

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

117,500,000

 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

 

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

9.02%

 

12

 

TYPE OF REPORTING PERSON

 

CO
         

 

 

 
 

 

CUSIP No 88337C102   Page 3 of 5

 

Item 1(a).   Name of Issuer:
     
    Therapy Cells, Inc.
     
Item 1(b).   Address of Issuer’s Principal Executive Offices:
     
    500 Hazelwood Road
Venice, FL 34293
     
Item 2(a).   Name of Person Filing:
     
    Blackbridge Capital, LLC
     
Item 2(b).   Address of Principal Business Office or, if None, Residence:
     
    450 7th Avenue, Suite 601, New York, New York 10023
     
Item 2(c).   Citizenship:
     
    Incorporated under the laws of the state of Delaware
     
Item 2(d).   Title of Class of Securities:
     
    Common Stock
     
Item 2(e).   CUSIP Number:
     
    88337C102
     
Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

 

  (a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
       
  (b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) o Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

 
 

 

CUSIP No 88337C102   Page 4 of 5

 

  (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) o A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
       
  (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) o A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
       
  (j) o Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Item 4. Ownership.
   
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount beneficially owned:
     
    117,500,000
     
  (b) Percent of class:
     
    9.02%
     
  (c) Number of shares as to which such person has:
     
    (i) Sole power to vote or to direct the vote
       
      117,500,000
       
    (ii) Shared power to vote or to direct the vote
       
      0
       
    (iii) Sole power to dispose or to direct the disposition of
       
      117,500,000
       
    (iv) Shared power to dispose or to direct the disposition of
       
      0

 

 
 

 

CUSIP No 88337C102   Page 5 of 5

 

Item 5. Ownership of Five Percent or Less of a Class.
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ]
   
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
   
  N/A
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
   
  N/A
   
Item 8. Identification and Classification of Members of the Group.
   
  N/A
   
Item 9. Notice of Dissolution of Group.
   
  N/A
   
Item 10. Certification.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: 12/18/2014      
       
  Signature: /s/ Alexander Dillon  
  Name: Alexander Dillon  
  Title: Managing Partner  
         

 

Top
Filing Submission 0001171520-14-000806   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 12:53:04.1am ET